Tyramine and monoamine oxidase inhibitors as modulators of the mitochondrial membrane permeability transition

L Marcocci1, U De Marchi, M Salvi

  • 1Department of Biochemical Sciences and CNR Center of Molecular Biology, University of Rome La Sapienza, Rome, Italy.

Insights

Tyramine triggers mitochondrial permeability transition (MPT) in rat liver mitochondria by generating hydrogen peroxide and aldehyde. MAO inhibitors also modulate MPT, suggesting complex interactions.

Area of Science:

  • Mitochondrial Physiology
  • Biochemistry
  • Enzymology

Background:

  • Monoamine oxidases (MAOs) A and B metabolize substrates like tyramine.
  • Mitochondrial membrane permeability transition (MPT) is a critical event in cell death.
  • Calcium ions (Ca2+) and reactive oxygen species can induce MPT.

Purpose of the Study:

  • To investigate the role of tyramine and its metabolites in inducing MPT in rat liver mitochondria.
  • To explore the involvement of MAO activity and its products in MPT.
  • To examine the modulatory effects of MAO inhibitors on MPT.

Main Methods:

  • Incubation of isolated rat liver mitochondria with varying concentrations of tyramine.
  • Measurement of mitochondrial swelling, membrane potential, ion efflux (Mg2+, Ca2+), and pyridine nucleotide oxidation.
  • Assessment of the effects of cyclosporin A, ADP, dithioerythritol, N-ethylmaleimide, catalase, and MAO inhibitors (clorgyline, pargyline).

Main Results:

  • Tyramine (100-500 mM) with Ca2+ induced MPT, evidenced by swelling, membrane potential collapse, ion efflux, and nucleotide oxidation.
  • These tyramine-induced effects were abolished by MPT inhibitors and partially reduced by catalase, indicating roles for hydrogen peroxide and aldehyde.
  • Higher tyramine concentrations (1-2 mM) were ineffective or inhibitory, while MAO inhibitors protected against tyramine-induced MPT but also inhibited Ca2+-induced MPT.

Conclusions:

  • Tyramine can induce MPT in mitochondria, likely through MAO-generated hydrogen peroxide and aldehyde.
  • MAO inhibitors (clorgyline, pargyline) modulate MPT, suggesting they act as direct effectors or influence metabolite generation.
  • Tyramine, clorgyline, and pargyline are identified as modulators of mitochondrial membrane permeability transition.

Related Concept Videos

Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
Adrenergic Agonists: Indirect-Acting Agents01:25

Adrenergic Agonists: Indirect-Acting Agents

Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
Translocation of Proteins into the Mitochondria01:19

Translocation of Proteins into the Mitochondria

Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Neurochemical Transmission: Sites of Drug Action01:26

Neurochemical Transmission: Sites of Drug Action

Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...